VE-cadherin at a glance

Cell and Tissue Research

Volumn 355, Issue 3, 2014, Pages 515-522

  Bravi, Luca ^a   Dejana, Elisabetta ^a,b   Lampugnani, Maria Grazia ^a,c  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Angiogenesis; Cell to cell junctions; Endothelium; Permeability; VE cadherin

Indexed keywords

CADHERIN; LEUKOCYTE ANTIGEN; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL; CHEMISTRY; HUMAN; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD; CADHERINS; HUMANS;

EID: 84899422507     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-014-1843-7     Document Type: Article

References (67)

1. Adam AP, Sharenko AL, Pumiglia K, Vincent PA (2010) Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J Biol Chem 285:7045-7055
2. Baluk P et al (2007) Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204:2349-2362
3. Baluk P, Hashizume H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15:102-111
4. Baumeister U et al (2005) Association of Csk to VE-cadherin and inhibition of cell proliferation. Embo J 24:1686-1695
5. Boulday G et al (2011) Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med 208:1835-1847
6. Breier G et al (1996) Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood 87:630-641
7. Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417-427
8. Carmeliet P et al (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98:147-157
9. Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149:1192-1205
10. Collisson EA, Carranza DC, Chen IY, Kolodney MS (2002) Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells. J Invest Dermatol 119:1172-1176
11. Davis ME et al (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464:1067-1070
12. Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16:209-221
13. Fukuhara S et al (2008) Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 10:513-526
14. Gavard J, Gutkind JS (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8:1223-1234
15. Gavard J, Patel V, GutkindJS (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14:25-36
16. Giampietro C et al (2012) Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood 119:2159-2170
17. Glading A, Han J, Stockton RA, Ginsberg MH (2007) KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 179:247-254
18. Hayashi M et al (2013) VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat Commun 4:1672
19. Iden S et al (2006) A distinct PAR complex associates physically with VE-cadherin in vertebrate endothelial cells. EMBO Rep 7:1239-1246
20. Kam Y, Quaranta V (2009) Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PLoS ONE 4:e4580
21. Kooistra MR, Corada M, Dejana E, Bos JL (2005) Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579:4966-4972
22. Korswagen HC, Herman MA, Clevers HC (2000) Distinct beta-catenins mediate adhesion and signalling functions in C. elegans. Nature 406:527-532
23. Kronstein R et al (2012) Caveolin-1 opens endothelial cell junctions by targeting catenins. Cardiovasc Res 93:130-140
24. Lampugnani MG (2012) Endothelial cell-to-cell junctions: adhesion and signaling in physiology and pathology. Cold Spring Harb Perspect Med 2
25. Lampugnani MG et al (1997) Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J Cell Sci 110(Pt 17):2065-2077
26. Lampugnani MG et al (1995) The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129:203-217
27. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E (2006) Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 174:593-604
28. Lampugnani MG et al (2010) CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 123:1073-1080
29. Lampugnani MG et al (1992) A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118:1511-1522
30. Lampugnani MG et al (2002) VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol Biol Cell 13:1175-1189
31. Maddaluno L et al (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498:492-496
32. Maher MT, Flozak AS, Stocker AM, Chenn A, Gottardi CJ (2009) Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol 186:219-228
33. May C et al (2005) Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood 105:4337-4344
34. Mazzone M et al (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136:839-851
35. Miyoshi J, Takai Y (2007) Nectin and nectin-like molecules: biology and pathology. Am J Nephrol 27:590-604
36. Nanes BA et al (2012) p120-catenin binding masks an endocytic signal conserved in classical cadherins. J Cell Biol 199:365-380
37. Navarro P et al (1995) Catenin-dependent and -independent functions of vascular endothelial cadherin. J Biol Chem 270:30965-30972
38. Nawroth R et al (2002) VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. Embo J 21:4885-4895
39. Nelson WJ (2008) Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem Soc Trans 36:149-155
40. Nitta T et al (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-660
41. Oas RG et al (2010) p120-Catenin is required for mouse vascular development. Circ Res 106:941-951
42. Orsenigo F et al (2012) Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3:1208
43. Pannekoek WJ et al (2011) Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. Cell Signal 23:2056-2064
44. Park HJ et al (2002) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 91:143-150
45. Pokutta S, Drees F, Yamada S, Nelson WJ, Weis WI (2008) Biochemical and structural analysis of alpha-catenin in cell-cell contacts. Biochem Soc Trans 36:141-147
46. Potter MD, Barbero S, Cheresh DA (2005) Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 280:31906-31912
47. Rampersad SN et al (2010) Cyclic AMP phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a vascular endothelial cadherin (VE-Cad)-based signaling complex and controls cAMP-mediated vascular permeability. J Biol Chem 285:33614-33622
48. Rudini N et al (2008) VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J 27:993-1004
49. Saharinen P et al (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10:527-537
50. Sakurai A et al (2006) MAGI-1 is required for Rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesion. Mol Biol Cell 17:966-976
51. Sanson B, White P, Vincent JP (1996) Uncoupling cadherin-based adhesion from wingless signalling in Drosophila. Nature 383:627-630
52. Simionescu M, Simionescu N, Palade GE (1976) Characteristic endothelial junctions in different segments of the vascular system. Thromb Res 8:247-256
53. Spindler V, Schlegel N, Waschke J (2010) Role of GTPases in control of microvascular permeability. Cardiovasc Res 87:243-253
54. Stahl S et al (2008) Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex. Hum Mutat 29:709-717
55. Stockton RA, Shenkar R, Awad IA, Ginsberg MH (2010) Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207:881-896
56. Suzuki S, Sano K, Tanihara H (1991) Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell Regul 2:261-270
57. Taddei A et al (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923-934
58. Thanou M, Gedroyc W (2013) MRI-Guided Focused Ultrasound as a New Method of Drug Delivery. J Drug Deliv 2013:616197
59. Thoreson MA et al (2000) Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol 148:189-202
60. Turowski P et al (2008) Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J Cell Sci 121:29-37
61. Tyler RC, Peterson FC, Volkman BF (2010) Distal interactions within the par3-VE-cadherin complex. Biochemistry 49:951-957
62. Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ (2000) SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 275:5983-5986
63. van Wetering S et al (2002) Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci 115:1837-1846
64. Whitehead KJ et al (2009) The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15:177-184
65. Yamaoka-Tojo M et al (2006) IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis. Arterioscler Thromb Vasc Biol 26:1991-1997
66. Yamashita K et al (2007) Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons. Brain Res 1154:215-224
67. Zanetti A et al (2002) Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling. Arterioscler Thromb Vasc Biol 22:617-622